Kirkland-based heart care company Cardiac Dimensions on Thursday raised a $53 million Series E round.

Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has raised $53 million ...

Doctors at Duke Health have successfully performed the world’s first living mitral valve replacement, saving three lives in North Carolina.

The room was filled with the sound of pens clicking and notes being written as attendees listened to various faculty members ...

Memorial Health System’s Department of Cardiology celebrated its 100th transcatheter aortic valve replacement procedure, performed by Dr. Jason Schott, interventional cardiologist, and Dr. Geoffrey R.

Memorial Health System’s Department of Cardiology marked a major milestone in heart-healthy care, celebrating its 100th ...

Payment will be provided when TTVR is delivered for an FDA-approved indication in the context of a CMS-approved study.

DurAVR ® THV demonstrated a favorable hemodynamic profile sustained to one-year, with an Effective Orifice Area (EOA) of 2.1 + 0.2 cm 2, a Mean Pressure Gradient (MPG) of 8.6 + 2.6 mmHg and Doppler ...

Anteris Technologies Global Corp.’s AVR share price has dipped by 10.16%, which has investors questioning if this is right time to buy.

Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s ...

Cardiac Dimensions announced today that it closed an oversubscribed Series E financing round worth $53 million.

Partial heart transplants provide a range of lifesaving options for children with complex congenital heart conditions, and ...